UPDATE 1-Conatus to get $50 mln in liver drug deal with Novartis, shares jump

Dec 19 (Reuters) - Swiss drugmaker Novartis on

Monday said it signed a licensing deal to co-develop a fatty

liver disease drug with Conatus Pharmaceuticals Inc,

under which the small U.S. company...

Read more